ALLOGENE THERAPEUTICS Trademark

Trademark Overview

On Friday, September 28, 2018, a trademark application was filed for ALLOGENE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ALLOGENE THERAPEUTICS trademark a serial number of 88136820. The federal status of this trademark filing is REGISTERED as of Tuesday, December 10, 2019. This trademark is owned by Allogene Therapeutics, Inc.. The ALLOGENE THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
allogene therapeutics

General Information

Serial Number88136820
Word MarkALLOGENE THERAPEUTICS
Filing DateFriday, September 28, 2018
Status700 - REGISTERED
Status DateTuesday, December 10, 2019
Registration Number5933530
Registration DateTuesday, December 10, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 26, 2019

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Description of MarkThe mark consists of the words "ALLOGENE THERAPEUTICS" next to a dotted circle design.
Goods and ServicesPharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, October 6, 2018
Primary Code005
First Use Anywhere DateTuesday, February 26, 2019
First Use In Commerce DateTuesday, February 26, 2019

Trademark Owner History

Party NameAllogene Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameAllogene Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameAllogene Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, October 2, 2018NEW APPLICATION ENTERED
Saturday, October 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 9, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, December 26, 2018ASSIGNED TO EXAMINER
Tuesday, January 1, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 1, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, January 1, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 1, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, January 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 18, 2019ASSIGNED TO LIE
Wednesday, February 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 26, 2019PUBLISHED FOR OPPOSITION
Tuesday, February 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 22, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, October 22, 2019SOU TEAS EXTENSION RECEIVED
Friday, October 25, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 22, 2019SOU EXTENSION 1 FILED
Friday, October 25, 2019SOU EXTENSION 1 GRANTED
Tuesday, October 22, 2019USE AMENDMENT FILED
Friday, October 25, 2019STATEMENT OF USE PROCESSING COMPLETE
Saturday, October 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 6, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, November 7, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 10, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, December 10, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, February 28, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 28, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 28, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 28, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 28, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 28, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, December 1, 2025TEAS SECTION 8 & 15 RECEIVED

Related Keywords

therapeutics allogene preparations pharmaceutical including therapy immunotherapy cell tumors namely treatment cancer